On Target Laboratories Information

On Target Laboratories discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery so cancerous tissue can be removed more completely. To date, there has been no reliable way for surgeons to assess the location and full extent of cancerous tissue while operating. Our molecular imaging technology, based on the pioneering work of Philip S. Low, PhD, Purdue University's Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, aims to reduce the uncertainty associated with finding and removing cancerous tissue during surgical procedures, helping surgeons to provide a more precise and complete surgical resection. Visit our website to learn more about On Target Laboratories and our targeted intraoperative molecular imaging agents.